miRoncol Health Launches AI Cancer Screening Blood Test in Ontario
miRoncol Health announced in a press release the launch of miCheckup, a miRNA blood test for multi cancer screening in Ontario. The service is available to eligible adults who have no cancer symptoms and costs CAD $1,299.
The test profiles microRNA molecules in a blood sample, then uses an AI algorithm to identify patterns associated with cancer. Customers request the test through a private virtual clinic, receive a requisition from a qualified practitioner when appropriate, and provide a blood sample at LifeLabs.
If the test detects a suspected cancer signal, the price covers a private whole body MRI when the scan is suitable and available through a participating facility. The company says a positive signal is not a cancer diagnosis, and customers should continue recommended screening and medical care regardless of the result.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Cancer researchers start testing AURORA AI co-scientists built at Harvard
Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners
BRIGHT Receives €3.7 Million for AI Cancer Microscope
Google Expands AI Tuberculosis Screening Across Africa and Indonesia
Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans
Daily AI Brief: the AI news that matters, in your inbox.